Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Cash (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Change in Cash for 15 consecutive years, with $24.5 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Cash rose 800.63% year-over-year to $24.5 million; the TTM value through Mar 2026 reached $34.6 million, up 187.03%, while the annual FY2025 figure was $12.9 million, 207.74% up from the prior year.
  • Change in Cash hit $24.5 million in Q1 2026 for Agios Pharmaceuticals, up from -$3.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $169.2 million in Q3 2024 and bottomed at -$177.5 million in Q4 2024.
  • Average Change in Cash over 5 years is -$5.3 million, with a median of $2.7 million recorded in 2025.
  • On a YoY basis, Change in Cash climbed as much as 928.66% in 2024 and fell as far as 843.48% in 2024.
  • Agios Pharmaceuticals' Change in Cash stood at $16.8 million in 2022, then soared by 42.01% to $23.9 million in 2023, then plummeted by 843.48% to -$177.5 million in 2024, then surged by 97.98% to -$3.6 million in 2025, then soared by 783.52% to $24.5 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at $24.5 million, -$3.6 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.